Cigna(US:CI) Prnewswire·2026-02-05 11:00Core Insights - The Cigna Group reported strong financial results for 2025, highlighting operational discipline and a robust portfolio of global health businesses [1][2] - The company aims to build on its momentum in 2026, leveraging innovations and a diversified business model [2] Financial Performance - Shareholders' net income for Q4 2025 was $1.2 billion, or $4.64 per share, down from $1.4 billion, or $5.13 per share in Q4 2024 [2][3] - For the full year 2025, shareholders' net income reached $6.0 billion, or $22.18 per share, compared to $3.4 billion, or $12.12 per share in 2024 [3][6] - Adjusted income from operations for Q4 2025 was $2.1 billion, or $8.08 per share, up from $1.8 billion, or $6.64 per share in Q4 2024 [3][6] - Total revenues for 2025 increased by 11% to $274.9 billion, driven by growth in Evernorth Health Services [6][9] Customer Relationships - Total customer relationships increased by 3% to 188.4 million as of December 31, 2025, reflecting new sales and expansion in Pharmacy Benefit Services [8][15] - Total pharmacy customers rose by 4% to 123.6 million, while total medical customers decreased by 5% to 18.1 million, primarily due to the HCSC transaction [15][21] Segment Performance - Evernorth Health Services saw adjusted revenues increase by 16% and adjusted income from operations increase by 3% for the full year 2025 compared to 2024 [16][20] - Cigna Healthcare's adjusted revenues for 2025 were $47.2 billion, down from $52.9 billion in 2024, largely due to the divestiture of certain businesses [18][21] Outlook for 2026 - The Cigna Group projects adjusted revenues for 2026 to be approximately $280 billion, with adjusted income from operations expected to be at least $7.95 billion, or at least $30.25 per share [24][25] - The company anticipates a continued focus on operational efficiency, with an adjusted SG&A expense ratio projected to be around 5.0% [25]